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Background: A novel biodegradable platform of drug eluting stents showed promising preliminary results, therefore the aim of this study was to 
compare paclitaxel eluting stents from biodegradable (LUC - Chopin, Balton, Poland) and durable (Taxus, Boston Scietific, USA) platform.
Methods: This is a multicenter retrospective registry of 393 consecutive patients with coronary artery disease who underwent PCI between June 
2006 and September 2008. We included patients with stable angina or non ST - elevation acute coronary syndrome and at least one significant 
lesion (>50% diameter stenosis) in the native coronary arteries. Two hundred and six patients recieved LUC Chopin stent, (LUC group) while 187 
Taxus (Taxus group). There were no significant differnces with regard to basic demographic and clinical data between LUC and Taxus groups except 
higher number of non ST-elevation myocardial Infarct (11,2% vs 6,1%, p=0,05) and a trend toward higher incidence of diabetes (39,6% vs. 30,2% 
p= 0,08) in LUC group. Additionaly, patients in Taxus group more often obtained complete revascularization (59,5% vs 51,8%, p=0,08).  
Results: At one year follow up target lesion revascularization (TLR) occured in 9,2% and 7,4% in LUC and Taxus groups (p=0,36), while target vessel 
revascularization (TVR) in 12,1% and 10,7% (p=0,42) respectively. There was also no differnece in Major Adverse Coronary and Cerebral Events 
between the study groups 16,6% vs. 15% (p=0,6). Kaplan Maier analysis showed no differnce in long term TLR and TVR - free survival (Log-rank 
p=0,19 and 0,23 respectively). Definite late stent thrombosis occured in 1,5% in LUC and 1% in Taxus group. Stent diameter of <2,5 mm was the 
only independent predictor of TLR .
Conclusions: Biodegradable polymer paclitaxel eluting stent is non inferior to durable, with regard to incidence of repeated revascularizations and 
MACCE.
